-
Once Again, Baird Predicts End To Tandem's 'Fantastic' Run
Friday, September 14, 2018 - 10:24am | 510Read More...Without pause, Tandem Diabetes Care Inc (NASDAQ: TNDM) has surged 1,915 percent year-to-date. One sell-side analyst said Friday that the medical device manufacturer's valuation has peaked. The Rating Baird Equity Research analyst Jeff Johnson downgraded Tandem from Outperform to...
-
Baird Sees 'Improved Odds' Tandem Diabetes Care Will Survive
Friday, March 23, 2018 - 2:41pm | 418Read More...Tandem Diabetes Care Inc (NASDAQ: TNDM), a medical technology company focused on the treatment of diabetes and insulin infusion therapy, has seen transformed from a "solid competitive" company in mid-2016 to one where it might not survive, according to Baird. But the company may boast the...
-
A Look At Teva's Paragard IUD Asset Sale To Cooper Companies, From Both Sides
Wednesday, September 13, 2017 - 9:14am | 590Read More...Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) said Tuesday it has agreed to sell its Paragard IUD product to Cooper Companies Inc (NYSE: COO) in a $1.1 billion cash deal. Teva also confirmed it will continue divesting the remaining assets it holds within the women's health portfolio along...
-
DexCom Diamond 2 Results Positive, Or At Least Not As Bad As Expected
Thursday, February 16, 2017 - 5:09pm | 449Read More...Reviewing the data from the second arm of DexCom, Inc.'s (NASDAQ: DXCM) Diamond study, Baird said the results are positive for Continuous Glucose Monitoring, or CGM, and modestly positive, or at least not as feared for insulin pumps. The results were inadvertently released through a poster at...
-
Patterson Companies: Something Sizeable This Way Comes
Tuesday, November 22, 2016 - 4:56pm | 438Read More...Shares of Patterson Companies, Inc. (NASDAQ: PDCO) plunged more than 23 percent to a new 52-week low of $36.46 as the company didn't announce an expected distribution deal with e-commerce giant Amazon.com, Inc. (NASDAQ: AMZN). Sentiment was also dented by the company’s lower-than-...
-
Baird Pulls Back The Jowls Of Patterson's Q1
Friday, August 26, 2016 - 3:55pm | 365Read More...Baird Equity Research analysts Jeff Johnson and Jason Bednar maintain Patterson Companies, Inc. (NASDAQ: PDCO) Neutral rating. However, the analysts trimmed their price target on the stock by $2 from $51 to $49. The comments come on the heels of the company delivering in-line results for the first...
-
Which Tech Giants Might Buy Applied Micro?
Wednesday, January 6, 2016 - 2:34pm | 353Read More...In a new report, Detwiler Fenton analyst Jeff Johnson discussed some big names that might have Applied Micro Circuits Corporation (NASDAQ: AMCC) on their shopping lists. According to Johnson, Applied Micro is the furthest along of the semiconductor companies working in the ARM server market....
